Check-Cap received CE mark for its C-Scan Capsule in January of this year, now the Isfiya, Israel-based company is setting its sights on the U.S. market.
Propeller Health, the University of Wisconsin-Madison, and the University of California, Berkeley, used digital medicine data obtained from a five-year study to find out how air pollution impacts the day-to-day lives of asthma sufferers.
Biomedical engineers at Georgia Tech have developed a smartphone app that uses photos of a patient's fingernails to determine whether the level of hemoglobin in their blood seems low.
Pear Therapeutics has received a nod from FDA to market reSET-O, an app used to help those with opioid use disorder stay in recovery programs.
FDA said interim results from sampling studies indicate higher-than-expected contamination rates after reprocessing of duodenoscopes currently on the market.
Olympus agreed to pay $85 million to settle a federal investigation of its that began in 2015. A former executive also pleaded guilty and faces up to a year in prison.
Osaka University researchers have developed an AI-based system that has the potential to differentiate between different types of cancer cells. The research could have major implications in the field of oncology.
The Galway, Ireland-based company has raised $30 million to help develop its approach to drain the excess fluid found in acute decompensated heart failure patients.
The company also released a weak outlook for 2019 and saw shares drop a little more than 17% as a result.
The partnership between Edwards Lifesciences and Bay Labs continues the trend of larger medtech firms teaming up with companies in the artificial intelligence space to enhance existing devices.
The medtech space was definitely piping hot with M&A activity earlier this year, but do firms still have that same thirst for deals going into 2019?
The robotic guidance and navigation system has already been used in surgeries in Greece, Germany, and Italy.
A recent breakthrough in the design of medical device cables is expected to enable a new generation of small, flexible, and intelligent catheters according to Japanese wire and cable supplier Junkosha.
The Marlborough, MA-based company said it could pick up a CE mark for the endoscopic ablation system sometime in mid-2019.